中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2014年
19期
16-17,18
,共3页
微创腰麻%瑞芬太尼%自控镇痛%分娩镇痛
微創腰痳%瑞芬太尼%自控鎮痛%分娩鎮痛
미창요마%서분태니%자공진통%분면진통
minimally invasive spinal anesthesia%remifentanil%patient-controlled analgesia%labor analgesia
目的:评价微创腰麻联合瑞芬太尼静脉自控镇痛这一新型分娩镇痛方式的应用价值。方法将医院收治的要求分娩镇痛的初产妇128例随机分为A组和B组,各64例。A组给予舒芬太尼微创腰麻联合瑞芬太尼静脉自控镇痛,B组给予舒芬太尼联合罗哌卡因硬膜外腔自控镇痛,观察记录镇痛效果、运动阻滞、产程时间、新生儿评分、总住院费用及不良反应发生情况等。结果两组产妇各时刻疼痛视觉模拟评分(VAS评分)均明显下降( P<0.05),但A组明显高于B组( P<0.05);所有产妇均未出现明显的运动阻滞;A组活跃期与B组无明显差异( P>0.05),而第二产程明显短于B组( P<0.05);两组顺产率无明显差异( P>0.05),B组剖宫产率为17.19%,明显高于A组的10.94%( P<0.05);两组新生儿生后1 min和5 min Apgar评分、生后15 min和出生后24 h神经行为与适应能力评分(24 hNACS评分)均在正常范围内,组间差异无统计学意义( P>0.05);A组在住院期间总费用较B组高( P<0.05);A组不良反应总发生率为17.19%,明显低于B组的28.13%( P<0.05)。结论微创腰麻联合瑞芬太尼静脉自控镇痛在产科分娩镇痛中,虽然花费较高,但镇痛效果确切、无明显运动阻滞且对新生儿无明显影响,还能缩短第二产程,降低剖宫产率和不良反应发生率,值得临床推广。
目的:評價微創腰痳聯閤瑞芬太尼靜脈自控鎮痛這一新型分娩鎮痛方式的應用價值。方法將醫院收治的要求分娩鎮痛的初產婦128例隨機分為A組和B組,各64例。A組給予舒芬太尼微創腰痳聯閤瑞芬太尼靜脈自控鎮痛,B組給予舒芬太尼聯閤囉哌卡因硬膜外腔自控鎮痛,觀察記錄鎮痛效果、運動阻滯、產程時間、新生兒評分、總住院費用及不良反應髮生情況等。結果兩組產婦各時刻疼痛視覺模擬評分(VAS評分)均明顯下降( P<0.05),但A組明顯高于B組( P<0.05);所有產婦均未齣現明顯的運動阻滯;A組活躍期與B組無明顯差異( P>0.05),而第二產程明顯短于B組( P<0.05);兩組順產率無明顯差異( P>0.05),B組剖宮產率為17.19%,明顯高于A組的10.94%( P<0.05);兩組新生兒生後1 min和5 min Apgar評分、生後15 min和齣生後24 h神經行為與適應能力評分(24 hNACS評分)均在正常範圍內,組間差異無統計學意義( P>0.05);A組在住院期間總費用較B組高( P<0.05);A組不良反應總髮生率為17.19%,明顯低于B組的28.13%( P<0.05)。結論微創腰痳聯閤瑞芬太尼靜脈自控鎮痛在產科分娩鎮痛中,雖然花費較高,但鎮痛效果確切、無明顯運動阻滯且對新生兒無明顯影響,還能縮短第二產程,降低剖宮產率和不良反應髮生率,值得臨床推廣。
목적:평개미창요마연합서분태니정맥자공진통저일신형분면진통방식적응용개치。방법장의원수치적요구분면진통적초산부128례수궤분위A조화B조,각64례。A조급여서분태니미창요마연합서분태니정맥자공진통,B조급여서분태니연합라고잡인경막외강자공진통,관찰기록진통효과、운동조체、산정시간、신생인평분、총주원비용급불량반응발생정황등。결과량조산부각시각동통시각모의평분(VAS평분)균명현하강( P<0.05),단A조명현고우B조( P<0.05);소유산부균미출현명현적운동조체;A조활약기여B조무명현차이( P>0.05),이제이산정명현단우B조( P<0.05);량조순산솔무명현차이( P>0.05),B조부궁산솔위17.19%,명현고우A조적10.94%( P<0.05);량조신생인생후1 min화5 min Apgar평분、생후15 min화출생후24 h신경행위여괄응능력평분(24 hNACS평분)균재정상범위내,조간차이무통계학의의( P>0.05);A조재주원기간총비용교B조고( P<0.05);A조불량반응총발생솔위17.19%,명현저우B조적28.13%( P<0.05)。결론미창요마연합서분태니정맥자공진통재산과분면진통중,수연화비교고,단진통효과학절、무명현운동조체차대신생인무명현영향,환능축단제이산정,강저부궁산솔화불량반응발생솔,치득림상추엄。
Objective To evaluate the application value of minimally invasive spinal anesthesia combined with remifentanil patient con-trolled epidural analgesia(PCEA)as a new type labor analgesia mode. Methods 128 primiparas requiring labor analgesia in our hospi-tal were randomLy divided into the group A and B,64 cases in each group. The group A was given sufentanil minimally invasive spinal anesthesia combined with the remifentanil PCEA,while the group B was given sufentanil combined with ropivacaine PCEA. The analgesic effect,motor block,duration of labor,neonatal Apgar scores,total hospital costs and occurrence situation of adverse reactions were ob-served and recorded. Results The visual analogue scale(VAS) scores at various timepoints in the two groups were significantly de-creased( P < 0. 05),but the group A was significantly higher the group B( P < 0. 05);all primiparas had no obvious motor block;the active period had no statistical significant difference between the group A and B( P > 0. 05),while the second stage of labor in the group A was significantly shorter than that in the group B( P < 0. 05);the smooth delivery rate had no statistical difference between the two groups ( P > 0. 05),the cesarean section rate in the group B was 17. 19%,which was higher than 10. 94% in the group A ( P < 0. 05);the neonatal 1min,5 min Apgar scores and the 15min,24h NACS scores in the two groups were within the normal ranges without statistical differences between the two groups ( P > 0. 05);the total hospital cost in the group A was higher than that in the group B ( P < 0. 05);the total occurrence rate of adverse reactions in the group A was lower than that in the group B (17. 19%vs. 28. 13%,P < 0. 05). Conclusion Minimally invasive spinal anesthesia combined with remifentanil PCEA in labor analgesia,although spending is higher,but the analgesic effect is exact without obvious motor block and with no obvious effect on the newborns,but also shorten the second stage of labor,reduce the cesarean section rate and the occurrence rate of adverse reactions,which is worthy of clin-ical promotion.